Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Slovak English |
| PhysicalDescription: | Obr., tab. |
| ISSN: | 0028-2685 |
| Subjects: |
Similar Items
Špatná odpověď nemocných s de novo akutními myeloidními leukémiemi s erytroblastickou či megakaryocytární dysplazií na léčbu standardními dávkami cytosin-arabinosidu a daunorubicinu
by: Lemež, Petr, et al.
by: Lemež, Petr, et al.
Changes in the toxicity and therapeutic efficacy of Daunorubicin linked with a biodegradable carrier
by: Hrdina, R., et al.
by: Hrdina, R., et al.
Cytotoxic and mutagenic in vitro effect of 7-0- epoxyalkyl derivatives of daunomycinone.
by: Šturdíková, M., et al.
by: Šturdíková, M., et al.
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubucin, etoposide and mitoxantrone may casue permanents oligoasthenozoospermia or amenorrhea in middle-aged patients
by: Lemež, Petr, et al.
by: Lemež, Petr, et al.
